N
NGNE
Neurogene
17.64
-0.98-5.26%After Hours: 17.64 0.00 0.00%17:09 02/20 EST
OPEN/PREV CLOSE18.38/18.62
TODAY RANGE17.32-18.80
VOL179.40K
MARKET CAP273.24M
52 WEEK RANGE6.88-37.27
AVG VOL (3M)156.23K
% TURNOVER1.16%
TURNOVER--
P/E (TTM)-4.2854
% RANGE6.39%
EPS(TTM)-4.1163
P/E(FORWARD)-4.1408
P/B0.9815
BVPS17.97
DIVIDEND--
P/S283.15
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP250.02M
SHARES OUTSTANDING15.49M
NEXT EARNINGS03/23-03/27
FREE FLOAT14.17M
LOT SIZE1
EX-DATE12/19/2023
News
Press Releases
Financial Reports
Profile
Reuters·02/05 12:30
Neurogene Inc. to Participate in Major Investor Conferences
Reuters·02/05 12:30
Neurogene Inc. nimmt an wichtigen Investorenkonferenzen teil
Reuters·02/04 21:01
BRIEF-Neurogene Announces Inducement Grant Under Nasdaq Listing Rule
Reuters·02/04 21:01
Neurogene Grants Stock Options to New Employee Under Inducement Plan
Dow Jones·01/26 13:55
Neurogene Price Target Announced at $50.00/Share by LifeSci Capital
TipRanks·01/26 12:55
Neurogene initiated with an Outperform at LifeSci Capital
Dow Jones·01/13 12:31
Neurogene Price Target Maintained With a $70.00/Share by HC Wainwright & Co.
Benzinga·01/13 12:20
HC Wainwright & Co. Reiterates Buy on Neurogene, Maintains $70 Price Target
TipRanks·01/13 11:36
Neurogene (NGNE) Gets a Buy from H.C. Wainwright
TipRanks·01/12 12:38
Neurogene outlines 2026 milestones for NGN-401 Rett therapy
Same Industry
Name/Symbol
Change%
Price